Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models
Authors
Keywords
-
Journal
Blood Cancer Journal
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-13
DOI
10.1038/s41408-023-00930-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pre‐treatment total metabolic tumour volumes in lymphoma: Does quantity matter?
- (2022) Tarec Christoffer El‐Galaly et al. BRITISH JOURNAL OF HAEMATOLOGY
- CAR T cells as a second-line therapy for large B-cell lymphoma: a paradigm shift?
- (2022) Jason Westin et al. BLOOD
- Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index
- (2022) N. George Mikhaeel et al. JOURNAL OF CLINICAL ONCOLOGY
- Diffuse Large B-Cell Lymphoma
- (2021) Laurie H. Sehn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study
- (2021) Lale Kostakoglu et al. HAEMATOLOGICA
- Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
- (2021) Hervé Tilly et al. NEW ENGLAND JOURNAL OF MEDICINE
- High total metabolic tumor volume at baseline allows discrimination of survival even in patients aged 60 to 80 years responding to R-CHOP
- (2020) Laetitia Vercellino et al. BLOOD
- International prognostic indices in diffuse large B-cell lymphoma (DLBCL): a comparison of IPI, R-IPI and NCCN-IPI
- (2020) Amy S Ruppert et al. BLOOD
- Prognostic indices in diffuse large B‐cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R‐CHOP 14 versus 21 phase 3 trial
- (2020) Mary Gleeson et al. BRITISH JOURNAL OF HAEMATOLOGY
- Statistical Challenges in Development of Prognostic Models in Diffuse Large B-Cell Lymphoma: Comparison Between Existing Models – A Systematic Review
- (2020) Jelena Jelicic et al. Clinical Epidemiology
- FDG-PET/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome - final result of a UK National Cancer Research Institute prospective study
- (2020) N. George Mikhaeel et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prognostic nutritional index and the prognosis of diffuse large b-cell lymphoma: a meta-analysis
- (2020) Chunyan Luan et al. Cancer Cell International
- Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma
- (2019) R. Andrew Harkins et al. Expert Review of Hematology
- Pretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing Chemotherapy
- (2019) Michael R Clausen et al. Clinical Epidemiology
- Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI
- (2018) Joel C. Wight et al. BLOOD REVIEWS
- C-statistic: A brief explanation of its construction, interpretation and limitations
- (2018) S.J. Caetano et al. EUROPEAN JOURNAL OF CANCER
- Novel prognostic index based on hemoglobin level and platelet count for diffuse large B-cell lymphoma, not otherwise specified in the R-CHOP era
- (2018) Shoko Nakayama et al. PLATELETS
- Available prognostic models for risk stratification of diffuse large B cell lymphoma patients: a systematic review
- (2018) Jelena Jelicic et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma
- (2017) Junshik Hong et al. Oncotarget
- Simplicity at the cost of predictive accuracy in diffuse large B-cell lymphoma: a critical assessment of the R-IPI, IPI, and NCCN-IPI
- (2017) Jorne Biccler et al. Cancer Medicine
- A new extranodal scoring system based on the prognostically relevant extranodal sites in diffuse large B-cell lymphoma, not otherwise specified treated with chemoimmunotherapy
- (2016) Hee Sang Hwang et al. ANNALS OF HEMATOLOGY
- Utility of a simple prognostic stratification based on platelet counts and serum albumin levels in elderly patients with diffuse large B cell lymphoma
- (2016) Yotaro Ochi et al. ANNALS OF HEMATOLOGY
- The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era
- (2016) T Kobayashi et al. Blood Cancer Journal
- The Danish National Lymphoma Registry: Coverage and Data Quality
- (2016) Bente Arboe et al. PLoS One
- Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma
- (2015) Matthew J. Maurer et al. AMERICAN JOURNAL OF HEMATOLOGY
- Body mass index and other anthropometric parameters in patients with diffuse large B-cell lymphoma: physiopathological significance and predictive value in the immunochemotherapy era
- (2015) Clémentine Sarkozy et al. LEUKEMIA & LYMPHOMA
- A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry
- (2015) Anne O. Gang et al. LEUKEMIA & LYMPHOMA
- External validation of multivariable prediction models: a systematic review of methodological conduct and reporting
- (2014) Gary S Collins et al. BMC Medical Research Methodology
- A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2-microglobulin
- (2014) Thomas Melchardt et al. BRITISH JOURNAL OF HAEMATOLOGY
- Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era
- (2013) Yu-Chung Huang et al. ANNALS OF HEMATOLOGY
- An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
- (2013) Z. Zhou et al. BLOOD
- Prognostic significance of absolute lymphocyte count at diagnosis of diffuse large B-cell lymphoma: a meta-analysis
- (2011) Jianhua Feng et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial
- (2011) Frédéric Peyrade et al. LANCET ONCOLOGY
- Interim positron emission tomography scan associated with international prognostic index and germinal center B cell-like signature as prognostic index in diffuse large B-cell lymphoma
- (2011) Hélène Lanic et al. LEUKEMIA & LYMPHOMA
- On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data
- (2011) Hajime Uno et al. STATISTICS IN MEDICINE
- Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic in
- (2010) Ranjana H. Advani et al. BRITISH JOURNAL OF HAEMATOLOGY
- Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+B-Cell Lymphoma in the Rituximab Era
- (2010) Marita Ziepert et al. JOURNAL OF CLINICAL ONCOLOGY
- Statistical methods for the assessment of prognostic biomarkers (Part I): Discrimination
- (2010) G. Tripepi et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Assessing the Performance of Prediction Models
- (2009) Ewout W. Steyerberg et al. EPIDEMIOLOGY
- Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma
- (2008) Maria Christina Cox et al. LEUKEMIA & LYMPHOMA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now